Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.

Latest updates to the Pembrolizumab in HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page version.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new deployment of the study page.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page shows a new Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor internal update to the page's version/metadata without altering the study content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a newer version of the site’s code or template. The change appears to be a backend patch rather than a modification to study content or user-facing data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe study page now indicates that enrollment is closed, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision update to v3.6.0 and formatting adjustments to the Intervention/Treatment label.SummaryDifference0.5%

- Check74 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.